AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Feb 19, 2019
29821_dirs_2019-02-19_d00b82f6-3057-4448-94cc-4a9ec481e000.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-02-14
Reporting Person: Brennan Daniel J. (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-14 | Common Stock | S | 22438.0000 | $39.5718 | Disposed | 279183.0000 | Direct |
| 2019-02-15 | Common Stock | M | 4152.0000 | $0.0000 | Acquired | 283335.0000 | Direct |
| 2019-02-15 | Common Stock | F | 1846.0000 | $40.0100 | Disposed | 281489.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-15 | Deferred Stock Units | $ | M | 4152.0000 | Disposed | 2023-02-15 | Common Stock (4152.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.42 to $39.66, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.